We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...

Sanofi India share price gained up to 6% in morning trades on Friday post Q4 results announced by the company after the ...

Zacks Research cut their Q2 2025 EPS estimates for shares of Sanofi in a research report issued on Wednesday, February 19th.

Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

It is often considered a cheap pharmaceutical stock due to its strong financial performance and growth potential. Sanofi (NASDAQ:SNY) reported €41.1 billion in total sales for FY 2024 ...

Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for priority review the supplemental biologics license application for ...

Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...

Bernstein analyst Florent Cespedes maintained a Buy rating on Sanofi (SNYNF – Research Report) today and set a price target of €114.00. The ...

Sanofi India, Schaeffler India share prices will remain in focus on Thursday as will declare dividend today. The meeting of ...

Teva and Sanofi's duvakitug showed promising results in a Phase 2b study for ulcerative colitis and Crohn's disease, with ...

The stock’s 50 day simple moving average is $49.34 and its 200-day simple moving average is $52.32. Sanofi has a 1-year low of $45.22 and a 1-year high of $58.97. The company has a debt-to ...